Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02811211 · ClinicalTrials.gov registry record
A Noninterventional Genotype/Phenotype Study of mGluR Mutations in Children and Adolescents With ADHD
A clinical trial, sponsored by Aevi Genomic Medicine, LLC, a Cerecor company.
- Completed
- Registry status
- 1,894
- Enrollment target
NCT02811211 is a clinical trial that has completed, run by Aevi Genomic Medicine, LLC, a Cerecor company. The registered enrollment target is 1,894 participants.
The verdict
NCT02811211 has completed, sponsored by Aevi Genomic Medicine, LLC, a Cerecor company.
- COMPLETED
- Registry status
- 1,894 participants
- Enrollment target
Study Summary
This noninterventional study will assess genomic changes in the metabotropic glutamate receptor (mGluR) network in children and adolescents with ADHD.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,894 participants |
| Start Date | 2016-02 |
| Est. Completion | 2017-01-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02811211
The ClinicalTrials.gov registry entry for NCT02811211 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,894 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Aevi Genomic Medicine, LLC, a Cerecor company, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02811211 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02811211 about?
NCT02811211 is a clinical study titled "A Noninterventional Genotype/Phenotype Study of mGluR Mutations in Children and Adolescents With ADHD". This noninterventional study will assess genomic changes in the metabotropic glutamate receptor (mGluR) network in children and adolescents with ADHD.
What is the current status of trial NCT02811211?
This trial is currently completed. The enrollment target is 1,894 participants. The study started on 2016-02. Estimated completion is 2017-01-06.
Who is sponsoring clinical trial NCT02811211?
This trial is sponsored by Aevi Genomic Medicine, LLC, a Cerecor company, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.